<code id='D15B250D5A'></code><style id='D15B250D5A'></style>
    • <acronym id='D15B250D5A'></acronym>
      <center id='D15B250D5A'><center id='D15B250D5A'><tfoot id='D15B250D5A'></tfoot></center><abbr id='D15B250D5A'><dir id='D15B250D5A'><tfoot id='D15B250D5A'></tfoot><noframes id='D15B250D5A'>

    • <optgroup id='D15B250D5A'><strike id='D15B250D5A'><sup id='D15B250D5A'></sup></strike><code id='D15B250D5A'></code></optgroup>
        1. <b id='D15B250D5A'><label id='D15B250D5A'><select id='D15B250D5A'><dt id='D15B250D5A'><span id='D15B250D5A'></span></dt></select></label></b><u id='D15B250D5A'></u>
          <i id='D15B250D5A'><strike id='D15B250D5A'><tt id='D15B250D5A'><pre id='D15B250D5A'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:7443
          Photo illustration based on photograph of The University of Texas MD Anderson Cancer Center in Houston, Texas in 2022
          Photo illustration: STAT; Photo: Adobe

          Three years ago, Jamie Lin, an early-career nephrologist at MD Anderson Cancer Center, made findings that could potentially help both save the kidneys of cancer patients and propel her career as a physician-scientist hoping to one day run her own lab. It was a promising start, but that’s when Lin says one of the Texas institute’s most powerful researchers interfered.

          Lin alleges in a lawsuit that prominent oncologist Padmanee Sharma derailed the publication of papers based on Lin’s work, threatened to undermine her fledgling career, and made defamatory comments about her in retaliation for resisting making Sharma an author on a paper and saying the senior researcher had made no substantial contribution to it.

          advertisement

          “Having this and another paper taken — what would’ve been important papers for my career,” Lin told STAT in an interview. “I’m sure that my career in research has just fallen off a cliff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          H5N1 bird flu outbreak: Second human case reported, in Michigan
          H5N1 bird flu outbreak: Second human case reported, in Michigan

          MicroscopicimageofH5N1avianinfluenzavirusparticles(inorange).CDCandNIAIDAsecondhumancaseofH5N1birdfl

          read more
          Continuity nursing helped my family in our darkest PICU moments
          Continuity nursing helped my family in our darkest PICU moments

          EssayauthorSarahMcCarthycuddleswithherdaughterMolly.CourtesySarahMcCarthyTheventilatoralarmwokemeat3

          read more

          Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

          CytokineticsCEORobertBlumspokelastweekatatalkduringSTAT’sBreakthroughSummitWestinSanFrancisco.SarahG